A review of international medical device regulations: Contact lenses and lens care solutions

Files in This Item:
Access to this item has been restricted by the copyright holder until:2019-05-14
File Description SizeFormat 
Peer Reviewed Author Draft Medical Device Contact Lenses Paper.pdf555.08 kBAdobe PDFDownload
Title: A review of international medical device regulations: Contact lenses and lens care solutions
Authors: Zaki, Marina
Pardo, Jesús
Carracedo, Gonzalo
Permanent link: http://hdl.handle.net/10197/9613
Date: 2019
Online since: 2019-02-26T14:48:03Z
Abstract: Medical devices are under strict regulatory oversight worldwide and such regulations prioritise patient safety and efficacy over anything else. Contact lenses fall under the medical device category - a result of direct contact with the eye. Equally regulated are the contact lens care product solutions, which include cleaning and maintenance solutions and lubricating and rewetting drops. In the USA, it is the FDA Centre for Devices and Radiological Health (CDRH) overseeing the regulations of medical devices, since 1976. In the European Union, it is the EU Commission responsible for regulating devices in Member States. The categorisation of contact lenses into medical devices is based on their inherent risk to the wearer. Contact lenses are subject to crucial regulatory oversight from concept to clinical evaluation, clinical investigations through to the finished lens product, and finally, strict conditions associated with their marketing approval including post-marketing surveillance. The physiochemical and manufacturing testing, such as biocompatibility testing alongside pre-clinical stability, sterility and microbiological testing are just some of the essential testing lenses must endure. Only through understanding the inherent risks and potential complications that can arise from contact lens wear, can one truly appreciate the need to adhere to strict regulations. The challenge however, lies in the need for more standardised regulations and flexible approaches, ensuring innovative device technologies reach patients in a timely manner without compromising public health and safety. This review highlights some key requirement, differences and similarities between the FDA and EU administrations in the approval of contact lenses.
Funding Details: European Commission Horizon 2020
Type of material: Journal Article
Publisher: Elsevier
Journal: Contact Lens and Anterior Eye
Copyright (published version): 2018 British Contact Lens Association
Keywords: Clinical investigationMarket approvalContact lensesCare solutionsClinical evaluation
DOI: 10.1016/j.clae.2018.11.001
Language: en
Status of Item: Peer reviewed
Appears in Collections:Conway Institute Research Collection
Biomolecular and Biomedical Science Research Collection

Show full item record

Google ScholarTM

Check

Altmetric


This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.